362 related articles for article (PubMed ID: 30061882)
1. Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen.
Lumley SF; McNaughton AL; Klenerman P; Lythgoe KA; Matthews PC
Front Immunol; 2018; 9():1561. PubMed ID: 30061882
[TBL] [Abstract][Full Text] [Related]
2. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
3. CD8
Zhang Y; Wu Y; Deng M; Xu D; Li X; Xu Z; Hu J; Zhang H; Liu K; Zhao Y; Gao F; Bi S; Gao GF; Zhao J; Liu WJ; Meng S
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950410
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8
Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700
[TBL] [Abstract][Full Text] [Related]
5. CD8+ T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C.
Nitschke K; Luxenburger H; Kiraithe MM; Thimme R; Neumann-Haefelin C
Dig Dis; 2016; 34(4):396-409. PubMed ID: 27170395
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection.
Morikawa K; Shimazaki T; Takeda R; Izumi T; Umumura M; Sakamoto N
Ann Transl Med; 2016 Sep; 4(18):337. PubMed ID: 27761441
[TBL] [Abstract][Full Text] [Related]
7. Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.
Oberhardt V; Hofmann M; Thimme R; Neumann-Haefelin C
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215790
[TBL] [Abstract][Full Text] [Related]
8. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
[TBL] [Abstract][Full Text] [Related]
9. The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection.
Schuch A; Hoh A; Thimme R
Front Immunol; 2014; 5():258. PubMed ID: 24917866
[TBL] [Abstract][Full Text] [Related]
10. Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection.
Ortega-Prieto AM; Dorner M
Vaccines (Basel); 2017 Sep; 5(3):. PubMed ID: 28862649
[TBL] [Abstract][Full Text] [Related]
11. Genomic Diversity of Hepatitis B Virus Infection Associated With Fulminant Hepatitis B Development.
Mina T; Amini Bavil Olyaee S; Tacke F; Maes P; Van Ranst M; Pourkarim MR
Hepat Mon; 2015 Jun; 15(6):e29477. PubMed ID: 26288637
[TBL] [Abstract][Full Text] [Related]
12. China's efforts to shed its title of "Leader in liver disease".
Li X; Xu WF
Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
[TBL] [Abstract][Full Text] [Related]
14. T-cell responses in hepatitis B and C virus infection: similarities and differences.
Schmidt J; Blum HE; Thimme R
Emerg Microbes Infect; 2013 Mar; 2(3):e15. PubMed ID: 26038456
[TBL] [Abstract][Full Text] [Related]
15. A comparative review of HLA associations with hepatitis B and C viral infections across global populations.
Singh R; Kaul R; Kaul A; Khan K
World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of HBV-Specific CD8
Heim K; Neumann-Haefelin C; Thimme R; Hofmann M
Front Immunol; 2019; 10():2240. PubMed ID: 31620140
[TBL] [Abstract][Full Text] [Related]
17. NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
Zheng M; Sun R; Wei H; Tian Z
J Immunol; 2016 May; 196(10):4122-31. PubMed ID: 27183639
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus polymerase-specific T cell epitopes shift in a mouse model of chronic infection.
Hasanpourghadi M; Novikov M; Newman D; Xiang Z; Zhou XY; Magowan C; Ertl HCJ
Virol J; 2021 Dec; 18(1):242. PubMed ID: 34876153
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen
Hoogeveen RC; Dijkstra S; Bartsch LM; Drescher HK; Aneja J; Robidoux MP; Cheney JA; Timm J; Gehring A; de Sousa PSF; Ximenez L; Peliganga LB; Pitts A; Evans FB; Boonstra A; Kim AY; Lewis-Ximenez LL; Lauer GM
J Hepatol; 2022 Nov; 77(5):1276-1286. PubMed ID: 35716846
[TBL] [Abstract][Full Text] [Related]
20. Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression.
Kawashima K; Isogawa M; Hamada-Tsutsumi S; Baudi I; Saito S; Nakajima A; Tanaka Y
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
